How Inven2 work with securing IPR: strategies and challenges in the field of oncology, Kirsten Stangeby, IPR Manager and Mohammed Amarzguioui, Technology Strategy Manager, both at Inven2.
What can be patented, how to proceed and what is absolutely crucial in the process? Elen Margrethe Brendeford, Patent examiner, Norwegian Industrial Property Office
Why is it important to protect your oncology innovation? Bjørn Lillekjendlie, Director Patent department, Norwegian Industrial Property Office (Patentstyret)
Welcome and latest update from Oslo Cancer Cluster Incubator, Ketil Widerberg, General Manager, Oslo Cancer Cluster
Oslo Cancer Cluster is an oncology research and industry cluster dedicated to improving the lives of cancer patients by accelerating the development of new cancer diagnostics and medicines.
We are a national non-profit member organization with about 90 members. Our members are Norwegian and international companies, research and financial institutions, university hospitals and organizations – all working in the cancer field.
